Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Return on Capital Employed (ROCE) | 12.9% | 10.6% | 6.1% | 32.3% | 9.2% | (15.3%) | 3.6% | 1.6% | 1.6% | 0.4% | 8.6% | 0.8% | 2.2% | (0.7%) | 5.0% | 12.3% | 6.9% | 16.7% | 21.0% | 1.7% |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Microsoft Corp's last 12-month Return on Capital Employed (ROCE) is 15.3%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Return on Capital Employed (ROCE) for Merck & Co., Inc. have been 12.9% over the past three years, and 14.4% over the past five years.
As of today, Merck & Co., Inc.'s Return on Capital Employed (ROCE) is 15.3%, which is higher than industry median of 12.8%. It indicates that Merck & Co., Inc.'s Return on Capital Employed (ROCE) is Good.